AIM ImmunoTech Inc. financial data

Symbol
AIM on NYSE, AIMI on OTC
Location
Ocala, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 17 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30.7 % -73.7%
Debt-to-equity -238 % -240%
Return On Equity 354 %
Return On Assets -257 % -74.4%
Operating Margin -13K % +11.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.85M shares -95.5%
Common Stock, Shares, Outstanding 2.76M shares -95.3%
Entity Public Float 20.8M USD -34.7%
Common Stock, Value, Issued 3K USD -94.9%
Weighted Average Number of Shares Outstanding, Basic 2.09M shares +263%
Weighted Average Number of Shares Outstanding, Diluted 2.09M shares +263%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 112K USD -41.1%
Revenue from Contract with Customer, Excluding Assessed Tax 112K USD -41.1%
Research and Development Expense 4.53M USD -41.5%
General and Administrative Expense 10.1M USD -50.5%
Costs and Expenses 14.7M USD -47.8%
Operating Income (Loss) -14.6M USD +47.8%
Net Income (Loss) Attributable to Parent -15.8M USD +34.2%
Earnings Per Share, Basic 6 USD/shares
Earnings Per Share, Diluted 6 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.35M USD +157%
Marketable Securities, Current 62K USD -99%
Accounts Receivable, after Allowance for Credit Loss, Current 1.18M USD -29.4%
Assets, Current 2.58M USD -66%
Property, Plant and Equipment, Net 80K USD -31.6%
Operating Lease, Right-of-Use Asset 436K USD -33.2%
Other Assets, Noncurrent 362K USD -86.7%
Assets 5.49M USD -59.6%
Accounts Payable, Current 1.25M USD -80%
Employee-related Liabilities, Current 17K USD +1600%
Accrued Liabilities, Current 679K USD -32.8%
Liabilities, Current 4.04M USD -60%
Operating Lease, Liability, Noncurrent 226K USD -48.3%
Liabilities 11.6M USD +8.38%
Retained Earnings (Accumulated Deficit) -437M USD -3.74%
Stockholders' Equity Attributable to Parent -6.08M USD -309%
Liabilities and Equity 5.49M USD -59.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.36M USD +51%
Net Cash Provided by (Used in) Financing Activities 660K USD -76.7%
Net Cash Provided by (Used in) Investing Activities 898K USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 2.76M shares -95.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -803K USD +62.5%
Deferred Tax Assets, Valuation Allowance 42.9M USD +16.5%
Deferred Tax Assets, Gross 42.9M USD +11.6%
Operating Lease, Liability 458K USD -31.5%
Depreciation 10K USD +11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.3M USD +40.2%
Property, Plant and Equipment, Gross 1.47M USD -5.72%
Operating Lease, Liability, Current 232K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 159K USD -34.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 258K USD -6.52%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30K USD -65.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 159K USD -20.5%
Deferred Tax Assets, Operating Loss Carryforwards 29M USD +15.5%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -33.5%
Additional Paid in Capital 431M USD +1.61%
Amortization of Intangible Assets 48K USD -2.04%
Share-based Payment Arrangement, Expense 0 USD -100%
Interest Expense 553K USD -26.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%